资讯
The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...
The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...
The survey found two-thirds of men don't feel comfortable speaking about their bladder weakness with a partner and 77% don't ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 4 July 2025, approved nogapendekin alfa inbakicept (Anktiva) for adults with ...
Scientists say there is an urgent need for aflatoxin control strategies in Pakistan's feed supply chain to improve animal ...
Urologists and physical therapists told DailyMail.com pelvic floor dysfunction has become increasingly common in men ages 30 ...
It affects almost 40 per cent of Australian women, yet the advice for those who suffer with incontinence is often inadequate.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果